Clinical trial
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829
Study timeline
Study start (actual)2019-11-04Date precision: day
Registry last updated2026-08-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diffuse Astrocytomaunresolved
Anaplastic Astrocytomaunresolved
Astrocytomaunresolved
Oligodendroglioma, Childhoodunresolved
Anaplastic Oligodendrogliomaunresolved
Glioblastomaunresolved
Pilocytic Astrocytomaunresolved
Giant Cell Astrocytomaunresolved
Pleomorphic Xanthoastrocytomaunresolved
Anaplastic Pleomorphic Xanthoastrocytomaunresolved
Angiocentric Gliomaunresolved
Chordoid Glioma of Third Ventricleunresolved
Gangliocytomaunresolved
Gangliogliomaunresolved
Anaplastic Gangliogliomaunresolved
Dysplastic Gangliocytoma of Cerebrellumunresolved
Papillary Glioneuronal Tumorunresolved
Rosette-forming Glioneuronal Tumorunresolved
Central Neurocytomaunresolved
Extraventricular Neurocytomaunresolved
Cerebellar Liponeurocytomaunresolved
Neurofibromatosis Type 1unresolved
Interventions
dabrafenibDRUG · verified · RxNorm: dabrafenib
trametinibDRUG · verified · RxNorm: trametinib
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03975829 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.